 G Protein-coupled receptors
|
|
Ion channels
|
|
Nuclear receptors
|
|
Protein kinases
|
|
 Cytokines and receptors
|
Cytokines
|
Interleukins
|
Interferons
|
CSF and other factors
|
Chemokines
|
Tumor necrosis factors
|
Transforming growth factors (RSTK-binding)
|
Growth factors (RTK-binding)
|
PGF [HSA:5228] [KO:K16859]
|
VEGFA [HSA:7422] [KO:K05448]
|
 D06409 Bevacizumab (USAN) <JP/US>
D09574 Aflibercept (USAN/INN) <JP/US>
D05386 Pegaptanib sodium (JAN/USAN)
D05697 Ranibizumab (USAN/INN) <JP/US>
D11083 Brolucizumab (USAN/INN) <JP/US>
D11517 Abicipar pegol (USAN/INN)
D11516 Faricimab (USAN/INN) <JP/US>
D08874 Bevasiranib sodium (USAN)
D10819 Aflibercept beta (genetical recombination) (JAN) <JP>
D11126 Navicixizumab (USAN/INN)
D11244 Vanucizumab (USAN/INN)
D11642 Dilpacimab (USAN/INN)
D11890 Emvododstat (USAN)
D12507 Tarcocimab (INN)
D12508 Tarcocimab tedromer (INN)
D12808 Ivonescimab (USAN/INN)
|
VEGFB [HSA:7423] [KO:K16858]
|
IGF1 [HSA:3479] [KO:K05459]
|
IGF2 [HSA:3481] [KO:K13769]
|
NGF [HSA:4803] [KO:K02582]
|
HGF [HSA:3082] [KO:K05460]
|
TGFA [HSA:7039] [KO:K08774]
|
EREG [HSA:2069] [KO:K09784]
|
ANGPT1 [HSA:284] [KO:K05465]
|
ANGPT2 [HSA:285] [KO:K05466]
|
ANGPTL3 [HSA:27329] [KO:K22288]
|
FGF19 [HSA:9965] [KO:K22603]
|
FGF21 [HSA:26291] [KO:K22429]
|
FGF23 [HSA:8074] [KO:K22428]
|
Cytokine receptors
|
Pattern recognition receptors
|
|
Cell surface molecules and ligands
|
|
Transporters
|
|
Enzymes
|
|
Nucleic acids
|
|
Not elsewhere classified
|
Target-based Classification of Drugs